Novan Inc Performance
| NOVNDelisted Stock | USD 0.13 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.68, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Novan's returns are expected to increase less than the market. However, during the bear market, the loss of holding Novan is expected to be smaller as well. Novan Inc right now secures a risk of 0.0%. Please verify Novan Inc treynor ratio and day median price , to decide if Novan Inc will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Novan Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Novan is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 47.7 M |
Novan |
Novan Relative Risk vs. Return Landscape
If you would invest 13.00 in Novan Inc on August 27, 2024 and sell it today you would earn a total of 0.00 from holding Novan Inc or generate 0.0% return on investment over 90 days. Novan Inc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Novan, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Novan Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novan's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Novan Inc, and traders can use it to determine the average amount a Novan's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NOVN |
Based on monthly moving average Novan is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novan by adding Novan to a well-diversified portfolio.
Novan Fundamentals Growth
Novan Stock prices reflect investors' perceptions of the future prospects and financial health of Novan, and Novan fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Novan Stock performance.
| Return On Equity | -20.99 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.59) % | |||
| Current Valuation | 27.74 M | |||
| Shares Outstanding | 28.02 M | |||
| Price To Earning | (1.49) X | |||
| Price To Book | 5.10 X | |||
| Price To Sales | 2.30 X | |||
| Revenue | 23.61 M | |||
| EBITDA | (33.76 M) | |||
| Cash And Equivalents | 14.9 M | |||
| Cash Per Share | 0.61 X | |||
| Total Debt | 3.93 M | |||
| Debt To Equity | 4.30 % | |||
| Book Value Per Share | (0.10) X | |||
| Cash Flow From Operations | (30.88 M) | |||
| Earnings Per Share | (0.84) X | |||
| Total Asset | 90.33 M | |||
| Retained Earnings | (310.28 M) | |||
| Current Asset | 12.51 M | |||
| Current Liabilities | 5.49 M | |||
About Novan Performance
By examining Novan's fundamental ratios, stakeholders can obtain critical insights into Novan's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Novan is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Novan, Inc., a medical dermatology company, focuses on researching, developing, and commercializing therapeutic products for skin diseases. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Novan operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.Things to note about Novan Inc performance evaluation
Checking the ongoing alerts about Novan for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Novan Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Novan Inc is not yet fully synchronised with the market data | |
| Novan Inc has some characteristics of a very speculative penny stock | |
| Novan Inc has a very high chance of going through financial distress in the upcoming years | |
| Novan Inc currently holds 3.93 M in liabilities with Debt to Equity (D/E) ratio of 4.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novan Inc has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Novan's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 23.61 M. Net Loss for the year was (31.31 M) with profit before overhead, payroll, taxes, and interest of 313 K. | |
| Novan Inc currently holds about 14.9 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Novan's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Novan's stock is overvalued or undervalued compared to its peers.
- Examining Novan's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Novan's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Novan's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Novan's stock. These opinions can provide insight into Novan's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Novan Stock
If you are still planning to invest in Novan Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novan's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |